NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Navan, Inc. (NASDAQ:NAVN) and Corcept Therapeutics Incorporated (NASDAQ:CORT). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.Navan, Inc. (NASDAQ:NAVN)Lead Plaintiff Deadline: April 24, 2026On October 30, 2025, Navan conducted its initial public offering, selling approximately 36.9 million shares at $25.00 per share. According to the complaint filed in the U.S. District of California, Northern District and captioned McCown v. Navan, Inc., Case No. 5:26-cv-01550, the Offering Documents used to effectuate Navan's IPO were false and misleading and omitted to state that, at the time of the offering, the Company had increased its "sales and marketing" expenses. As the truth about the Company's business reached the market, the value of its shares declined dramatically, causing Navan investors to suffer significant damages. Indeed, by the commencement of the action, Navan's shares traded as low as $9.01 per share, representing ...Full story available on Benzinga.com